ArticleScientific reports2026
Camellia sinensis-synthesized silver nanoparticles and meropenem combination against extensively drug-resistant Klebsiella pneumoniae.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Silver Nanoparticles in Donkey Semen Stored at 17°C: Effect on Sperm Parameters and Bacterial Growth.Reproduction in domestic animals = Zuchthygiene · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New strategies against antimicrobial resistance are urgently needed to address the challenges and health consequences posed by extensively drug-resistant (XDR) clinical isolates. This study explored how effective the green-synthesized silver nanoparticles alone or in combination with meropenem are in combating XDR Klebsiella pneumoniae. Klebsiella pneumoniae (K. pneumoniae) isolates were collected from several clinical labs and identified. After carrying out antimicrobial susceptibility testing, XDR isolates were selected for genotypic analysis using ERIC-PCR, and antibiotic resistance genes were identified. Silver nanoparticles (AgNPs) were synthesized using a Camellia sinensis (green tea) extract and characterized using UV-Vis spectroscopy, transmission electron microscopy (TEM), and X-ray diffraction (XRD). Particle size analysis was conducted to determine the physicochemical properties of the synthesized AgNPs. The AgNPs antibacterial effect alone or in combination with meropenem was carried out using the agar-well diffusion method, and the minimum inhibitory concentration (MIC), multiple antibiotic resistance (MAR) index and fractional inhibitory concentration index (FICI) were determined. Of the collected isolates, 67 were identified as K. pneumoniae, and 92.5% were considered XDR. Results showed that 10 (14.9%) and 57 (85.1%) isolates exhibited MAR index from 0.58 to 0.74, and 0.79-1.00, respectively. Upon genotypic analysis, 29 isolates were selected for further studies based on their unique or significant clustering patterns. The synthesized AgNPs exhibited strong antimicrobial activity against XDR K. pneumoniae strains, with inhibition zones ranging from 10 mm to 25 mm. The MIC of AgNPs ranged from 336.17 to 672.35 µg/mL. The fractional inhibitory concentration index (FICI) proved enhanced antimicrobial activity with partial (34.5%) and complete synergistic (65.5%) effects in the tested 29 nonclonal clinical isolates when AgNPs were combined with meropenem. In conclusion, a combination of AgNPs with meropenem is a useful alternative approach in combating XDR K. pneumoniae. Further studies are recommended for the use of this approach in clinical settings based on its benefits to enhance treatment outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.